Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Louisiana Blue | 00687 Select Transplant ImmunosuppressantsPayerPolicy · BCBSLA-00687-4FF1F8CA0E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00686 romosozumab aqqg (Evenity)PayerPolicy · BCBSLA-00686-E9EB85DA8F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00685 brexanolone (Zulresso)- Retired PolicyPayerPolicy · BCBSLA-00685-396BF66399 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00684 Transurethral Water Vapor Thermal Therapy (Rezum) and Transurethral Water Jet Ablation (Aquablation) for Benign Prostatic HypertrophyPayerPolicy · BCBSLA-00684-7B5BAA2F7C | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00683 Surgical and Ablative Treatments for Chronic HeadachesPayerPolicy · BCBSLA-00683-C6B92AE7CB | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00682 Ambulatory Event Monitors and Mobile Cardiac Outpatient Telemetry-Retired PolicyPayerPolicy · BCBSLA-00682-DC776A1D92 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00681 esketamine (Spravato)PayerPolicy · BCBSLA-00681-A3CC641509 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00679 Interspinous Fixation (Fusion) DevicesPayerPolicy · BCBSLA-00679-A02639A1DB | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00678 emapalumab-lzsg (Gamifant)PayerPolicy · BCBSLA-00678-EC4FEB6E97 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00677 risankizumab-rzaa (Skyrizi)PayerPolicy · BCBSLA-00677-26FB397BF1 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00676 amifampridine (Firdapse)PayerPolicy · BCBSLA-00676-E9E893CAB9 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00675 elapegademase-lvlr (Revcovi)PayerPolicy · BCBSLA-00675-F45370E72C | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00674 Responsive Neurostimulation for the Treatment of Refractory Focal EpilepsyPayerPolicy · BCBSLA-00674-8F10C7BD80 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00673 Powered Exoskeleton for Ambulation in Patients With Lower-Limb DisabilitiesPayerPolicy · BCBSLA-00673-5D89896951 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00672 Myocardial Strain Imaging-Retired PolicyPayerPolicy · BCBSLA-00672-CF80014B14 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00671 ravulizumab (Ultomiris), eculizumab ProductsPayerPolicy · BCBSLA-00671-A09B081FA9 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00670 Transthyretin Silencers for the Treatment of Transthyretin-Mediated Amyloidosis in Adult PatientsPayerPolicy · BCBSLA-00670-3176DAA9C5 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00669 Select Loteprednol Ophthalmic ProductsPayerPolicy · BCBSLA-00669-B663E8925A | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00668 Select dexchlorpheniramine ProductsPayerPolicy · BCBSLA-00668-51E563908D | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00667 Select Injectable Testosterone ProductsPayerPolicy · BCBSLA-00667-EF7D38DBEE | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00666 Implantable Infusion Pump for Pain and Spasticity- Retired PolicyPayerPolicy · BCBSLA-00666-51AACD485A | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00665 cenegermin-bkbj (Oxervate)PayerPolicy · BCBSLA-00665-087FFFEC41 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00664 Genetic Testing for Alpha1-Antitrypsin Deficiency - Retired PolicyPayerPolicy · BCBSLA-00664-18A6A8BDBE | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00663 amikacin suspension (Arikayce)PayerPolicy · BCBSLA-00663-0A5FA33539 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00662 Hydrogel Spacer use During Radiotherapy for Prostate Cancer-Retired PolicyPayerPolicy · BCBSLA-00662-248F5D5C7C | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00661 Xepi (ozenoxacin)-Retired PolicyPayerPolicy · BCBSLA-00661-0A10BF7610 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00660 Qbrexza (glycopyrronium)PayerPolicy · BCBSLA-00660-6B2D55847E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00659 Orilissa (elagolix)PayerPolicy · BCBSLA-00659-D6BBF4F81C | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00657 Minimally Invasive Treatment of Nasal Valve CollapsePayerPolicy · BCBSLA-00657-7A10812D5F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00656 Next-Generation Sequencing for the Assessment of Measurable Residual Disease- Retired PolicyPayerPolicy · BCBSLA-00656-38D9EF02C6 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00655 riluzole (Tiglutik)PayerPolicy · BCBSLA-00655-B1B6D626C1 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00654 lanadelumab-flyo (Takhzyro)PayerPolicy · BCBSLA-00654-94D2E64653 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00653 migalastat (Galafold)PayerPolicy · BCBSLA-00653-9533711915 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00652 Netarsudil Ophthalmic Products (Rhopressa, Rocklatan)PayerPolicy · BCBSLA-00652-24AF6AC9E7 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00651 tildrakizumab-asmn (Ilumya)PayerPolicy · BCBSLA-00651-6863AB44E3 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00650 lusutrombopag (Mulpleta)PayerPolicy · BCBSLA-00650-573B8C934E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00649 Siklos (hydroxyurea)PayerPolicy · BCBSLA-00649-042D8FE03F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00648 avatrombopag (Doptelet, Doptelet Sprinkle)PayerPolicy · BCBSLA-00648-DE2A013093 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00647 tolvaptan (Jynarque, generics)PayerPolicy · BCBSLA-00647-95933E76F4 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00646 Calcitonin Gene-Related Peptide (CGRP) AntagonistsPayerPolicy · BCBSLA-00646-A72333223B | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00645 Lucemyra, generics (lofexidine)PayerPolicy · BCBSLA-00645-1533EC2A58 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00644 pegvaliase-pqpz (Palynziq)PayerPolicy · BCBSLA-00644-5E59046C30 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00643 Gender Affirming SurgeryPayerPolicy · BCBSLA-00643-FA316543E9 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00642 Select Oral Oncology Drugs - Retired PolicyPayerPolicy · BCBSLA-00642-1937987857 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00641 Pharmacotherapy for Gaucher DiseasePayerPolicy · BCBSLA-00641-CF8DC10FF8 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00640 Topical Treatments for Dry Eye DiseasePayerPolicy · BCBSLA-00640-24F785F7EF | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00639 Saturation Biopsy for Diagnosis, Staging, and Management of Prostate CancerPayerPolicy · BCBSLA-00639-211820A05A | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00638 fostamatinib (Tavalisse)PayerPolicy · BCBSLA-00638-20B80CF093 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00637 baricitinib (Olumiant)PayerPolicy · BCBSLA-00637-752B1BE1FC | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00636 methergine/methylergonovine tabletsPayerPolicy · BCBSLA-00636-16D8814EAE | New policy |
|---|